glp-1 news today november 5 2025 Orforglipron, an Oral Small-Molecule Receptor Agonist for Obesity 5, DOI: 10.1056/NEJMdo008238 New for the treatment of obesity - and so many additional indications being studied GLP-1 Shortage = Over -

What works during semaglutide therapy may not be optimal during tirzepatide therapy, and vice versa

Hyperinsulinemia can reduce cell apoptosis and induce cell proliferation through insulin and the insulin-like growth factor-1 (IGF-1) pathway [14]

PMS includes both physical symptoms, like bloating, headache, and breast soreness, and emotional symptoms such as mood swings, anxiety, and difficulty sleeping

This is especially important for prescription weight loss medications, including GLP-1 treatments, because patients should receive care from a legitimate medical provider with appropriate screening, prescribing, monitoring, and follow-up

She will also make decisions about what cases are included in the lawsuit and what evidence is allowed to be used at trial